Surgical Experience and Complications in 50 Patients Treated with an Anular Closure Device Following Lumbar Discectomy.


Journal

Orthopaedic surgery
ISSN: 1757-7861
Titre abrégé: Orthop Surg
Pays: Australia
ID NLM: 101501666

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 14 01 2018
revised: 06 05 2018
accepted: 19 06 2018
entrez: 28 6 2019
pubmed: 28 6 2019
medline: 9 1 2020
Statut: ppublish

Résumé

To examine the results of an anular closure device for prevention of lumbar disc reherniation in daily routine practice. Fifty patients with large anular defects were treated with limited discectomy and a bone-anchored anular closure device. The device physically occludes the defect in the anulus fibrosus and is intended for prevention of lumbar disc reherniation. Pain scores on a visual analogue scale, back function on the Oswestry Disability Index, and neurological status were noted. Symptomatic reherniation and reoperation rates were assessed at each follow-up. Surgical findings and complications, device-related and/or procedure-related, were recorded. Follow-up was 6, 12, 26, and 52 weeks. Mean anular defect height/width was 4.6 mm/10.1 mm. The overall symptomatic reherniation and reoperation rate was 2%. During the 1-year follow-up period, mean back pain decreased from 43 to 8 (P < 0.001), leg pain decreased from 71 to 4 (P < 0.001), and the Oswestry Disability Index decreased from 46 to 5 (P < 0.001). Among 15 patients with preoperative neurological deficits, improvements in neurological function were noted in 14 (93%). There were no serious device-related complications. The presented study shows promising early results in using the anular closure device. The procedure is safe with significantly fewer reherniations than for patients with large anular defects without anular closure. Further studies with longer follow-up periods are warranted to prove these findings for long-term outcomes.

Identifiants

pubmed: 31243920
doi: 10.1111/os.12495
pmc: PMC6595107
doi:

Types de publication

Controlled Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

431-437

Informations de copyright

© 2019 The Authors. Orthopaedic Surgery published by Chinese Orthopaedic Association and John Wiley & Sons Australia, Ltd.

Références

Spine (Phila Pa 1976). 1999 Nov 15;24(22):2313-7
pubmed: 10586454
Spine (Phila Pa 1976). 2001 Mar 15;26(6):652-7
pubmed: 11246379
J Bone Joint Surg Am. 2003 Jan;85(1):102-8
pubmed: 12533579
J Neurosurg Spine. 2005 Mar;2(3):271-8
pubmed: 15796351
Spine (Phila Pa 1976). 2006 Mar 15;31(6):653-7
pubmed: 16540869
N Engl J Med. 2007 May 31;356(22):2245-56
pubmed: 17538084
Spine J. 2009 Mar;9(3):240-57
pubmed: 18809356
Spine (Phila Pa 1976). 2008 Dec 1;33(25):2789-800
pubmed: 19018250
Neurosurgery. 2009 Sep;65(3):574-8; discussion 578
pubmed: 19687703
Spine (Phila Pa 1976). 2009 Sep 1;34(19):2044-51
pubmed: 19730212
Spine (Phila Pa 1976). 2010 May 15;35(11):E488-504
pubmed: 20421859
Eur Spine J. 2011 Apr;20(4):513-22
pubmed: 20949289
Int Orthop. 2013 Aug;37(8):1511-7
pubmed: 23695881
J Spinal Disord Tech. 2015 Dec;28(10):E571-7
pubmed: 25089673
PLoS One. 2015 Mar 27;10(3):e0121816
pubmed: 25815514
Korean J Spine. 2012 Dec;9(4):340-7
pubmed: 25983843
Neurosurg Focus. 2015 Oct;39(4):E6
pubmed: 26424346
Medicine (Baltimore). 2016 Jan;95(2):e2378
pubmed: 26765413
Clin Spine Surg. 2016 Dec;29(10):454-460
pubmed: 27879508
J Bone Joint Surg Br. 1984 Nov;66(5):706-10
pubmed: 6501365
Spine (Phila Pa 1976). 1982 Nov-Dec;7(6):604-7
pubmed: 7167834
J Bone Joint Surg Br. 1996 Nov;78(6):965-72
pubmed: 8951017

Auteurs

Ardeshir Ardeshiri (A)

Department for Traumatology and Orthopaedics, Section for Spine Surgery, Klinikum Itzehoe, Itzehoe, Germany.

Larry E Miller (LE)

Miller Scientific Consulting, Asheville, North Carolina, USA.

Michael Synowitz (M)

Department for Neurosurgery, University Hospital Kiel, Kiel, Germany.

Senol Jadik (S)

Department for Neurosurgery, University Hospital Kiel, Kiel, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH